Ken Clement is the visionary Chairman, CEO, and Founder of Kensana Health, a pioneering force that has transformed the landscape of phytopharmaceuticals. Under Ken’s leadership Kensana Health has ascended to global prominence as an unrivaled authority in the development of Environmentally Modified Organisms (EMOs) and cutting-edge standardized growing techniques. Ken is beginning a new era in agricultural advancements.
In 2012, Mr. Clement developed a new sector in the Canadian phytopharmaceutical industry. His innovative thinking and trailblazing spirit guided the birth of plant standardization and ushered in the future of biological prescription drug registrations. In 2016, Mr. Clement grew his Canadian production facility by orchestrating a successful IPO with ABcann Global, at the time valued in excess of $400 Million Dollars.
Ken holds a distinguished chair at Guelph University’s esteemed Controlled Environment Systems Research Facility (CESRF), where revolutionary systems are harnessed to engineer optimal growth conditions for space exploration and the harshest environments on Earth. Research from the CESRF will be used to optimize Kensana’s standardized EMO growing techniques.
Ken’s journey extends beyond the corporate boundaries with his ownership of the Wellington Dukes Junior ‘A’ Hockey club. Under Ken’s leadership, the Duke’s have won their third OJHL championship and are one of the most sought after teams in the league.